Arrowstreet Capital
INDV icon

Arrowstreet Capital’s Indivior Pharmaceuticals INDV Stock Holding History

Arrowstreet Capital’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$70.8M Buy
2,323,264
+617,364
+36% +$20.4M 0.04% 399
2025
Q4 		$61.2M Buy
+1,705,900
New +$52.1M 0.04% 418
2024
Q3 		– Sell
-179,497
Closed -$2.83M – 1793
2024
Q2 		$2.83M Sell
179,497
-147,652
-45% -$2.66M ﹤0.01% 985
2024
Q1 		$7M Buy
327,149
+284,489
+667% +$5.34M 0.01% 796
2023
Q4 		$644K Sell
42,660
-291,876
-87% -$5.18M ﹤0.01% 1185
2023
Q3 		$7.26M Sell
334,536
-123,221
-27% -$2.81M 0.01% 593
2023
Q2 		$10.6M Buy
+457,757
New +$10.5M 0.01% 500

Other funds holding INDV

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
OCM
Oaktree Capital Management Los Angeles, California $5.91B AUM 42.97% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $2.17B AUM 169.27% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return